Buzdar, A. U., Suman, V. J., Meric-Bernstam, F., Leitch, A. M., Ellis, M. J., Boughey, J. C., . . . Hunt, K. K. (2018). Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial. JAMA Oncol.
Chicago Style citaatBuzdar, Aman U., Vera J. Suman, Funda Meric-Bernstam, Ann Marilyn Leitch, Matthew J. Ellis, Judy C. Boughey, Gary W. Unzeitig, Melanie E. Royce, en Kelly K. Hunt. "Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential Vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial." JAMA Oncol 2018.
MLA citatieBuzdar, Aman U., et al. "Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential Vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial." JAMA Oncol 2018.